Chronic kidney disease trials in Peru

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  Where

  Arequipa, Bellavista, Chorrillos, Cusco, Lima, Piura

  Age

  18 years and over

  People

  5,000 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06742723 · EU 2023-506460-14-00
• Phase 3Taking people
  A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  Where

  Callao, Chorrillos, Cusco, Lima, Piura, Trujillo

  Age

  18 years to 99 years

  People

  2,800 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07624305 · EU 2026-526114-90-00
• Phase 3Taking people
  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  Where

  Bellavista, Callao, Chorrillos, Cusco, Lima, Piura

  Age

  18 years and over

  People

  7,000 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07753993 · EU 2025-523994-41-00